- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01333618
Introducer Curving Technique for Tilt of Transfemoral Günther Tulip Inferior Vena Cava Filter
April 25, 2011 updated by: China Medical University, China
Introducer Curving Technique for Tilt of Transfemoral Günther Tulip Inferior Vena Cava Filter:A Randomized Double-Blind Comparison
It has been demonstrated that implantation of inferior vena cava filter was safe and effective in the prevention or reduction of fatal pulmonary thromboembolism in numerous clinical researches.
When acute deep venous thrombosis need transcatheter thrombolysis, transfemoral Günther Tulip Filter implantation could avoid catheter across the Günther Tulip Filter.
Although incidence of significant filter tilting (>10°) is not high (13%-16%), severe tilting of the Günther Tulip Filter may be associated with difficulty or sometimes impossibility of retrieval.
It has been reported that a simple technique of keeping tension of the delivery system may prevent significant tilting of the transjugular Günther Tulip Filter in an in-vitro study.
But no clinical study of prevention transfemoral Günther Tulip Filter from tilting has been reported.
The investigators conducted a randomized, controlled study to test whether the introducer curving technique is useful to decrease the extent of tilting of transfemoral Günther Tulip Filter.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study was designed as a double-blind randomized controlled trial, with research assessors and patients intended to be blind to the intervention status.
The staff members performing the assessment were not involved in implementing any aspect of the intervention.
108 patients were randomized to accept curving introducer Günther Tulip Filter and transcatheter thrombolysis or straight introducer Günther Tulip Filter and transcatheter thrombolysis.
The assessments include the tilting angle between the axes of inferior vena cava and Günther Tulip Filter after implantation; the tilting angle between the axes of inferior vena cava and Günther Tulip Filter before retrieval; the fluoroscopy time of Günther Tulip Filter retrieval; the rate of retrieval hook adhering vascular wall; the success rate of retrieval.
Study Type
Interventional
Enrollment (Actual)
108
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Liaoning
-
ShenYang, Liaoning, China, 110001
- Department of Radiology, the First Hospital of China Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 78 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- acute lower extremity deep vein thrombosis, diagnosed by vascular ultrasound and clinical history
Exclusion Criteria:
- both lower extremities deep vein thrombosis
- Inferior Vena Cava thrombosis
- refractory hypertension (blood pressure > 180/110mmHg)
- contraindication of thrombolysis
- the diameter of Inferior Vena Cava > 35mm or < 14mm
- Inferior Vena Cava venous anomalies
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: curving introducer
|
The Günther Tulip filter (Vena Cava MReye Filter Set; William Cook Europe, Bjaeverskov, Denmark) The amplitude of introducer curvature was 5°-15° less than the angle between the inferior vena cave axis and the approached iliac vein axis and the distance between the vertex of the curved angle and the hook of the filter was 2-4cm less than the distance between the level of the renal vein confluence and the furcation of inferior vena cave.
|
Placebo Comparator: straight introducer
|
The Günther Tulip filter (Vena Cava MReye Filter Set; William Cook Europe, Bjaeverskov, Denmark)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the tilting angle between the axes of Inferior Vena Cava and Günther Tulip Filter after implantation
Time Frame: just after filter implantation (up to 24 hours)
|
just after filter implantation (up to 24 hours)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the tilting angle between the axes of Inferior Vena Cava and Günther Tulip Filter before retrieval
Time Frame: just before filter retrieval (up to 90 days)
|
just before filter retrieval (up to 90 days)
|
the fluoroscopy time of Günther Tulip Filter retrieval
Time Frame: just after filter retrieval(up to 90 days)
|
just after filter retrieval(up to 90 days)
|
the rate of retrieval hook adhering vascular wall
Time Frame: just after filter retrieval(up to 90 days)
|
just after filter retrieval(up to 90 days)
|
the success rate of retrieval
Time Frame: just after filter retrieval(up to 90 days)
|
just after filter retrieval(up to 90 days)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Liang Xiao, Ph.D. M.D., First Hospital of China Medical University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2008
Primary Completion (Actual)
June 1, 2010
Study Completion (Actual)
September 1, 2010
Study Registration Dates
First Submitted
April 4, 2011
First Submitted That Met QC Criteria
April 11, 2011
First Posted (Estimate)
April 12, 2011
Study Record Updates
Last Update Posted (Estimate)
April 26, 2011
Last Update Submitted That Met QC Criteria
April 25, 2011
Last Verified
August 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LXiao-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Deep Venous Thrombosis
-
Hospital de Clinicas de Porto AlegreCompletedDeep Venous Thromboses | Deep Venous Thrombosis of Left Leg | Deep Venous Thrombosis of Right Leg | Deep Venous Thrombosis Proximal
-
Intermountain Health Care, Inc.TerminatedDeep Vein Thrombosis | Venous Thromboembolism | Deep Venous Thrombosis | Thrombus | Upper Extremity Deep Venous ThrombosisUnited States
-
Tong ZhuNot yet recruitingDeep Vein Thrombosis | Deep Venous Insufficiency
-
Maastricht University Medical CenterTerminatedRandomized Clinical Trial | Deep-Venous Thrombosis | Deep Venous StentingNetherlands
-
Imperial College LondonWithdrawnDeep Vein Thrombosis | Deep Venous Thrombosis of LegUnited Kingdom
-
University of Massachusetts, AmherstCompletedDeep Venous Thrombosis of Deep Femoral VeinUnited States
-
Ottawa Hospital Research InstituteUniversity of Alberta; Hamilton Health Sciences Corporation; Queen Elizabeth...CompletedThromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines (TRIM-Line)Cancer | Central Venous Catheter Thrombosis | Upper Extremity Deep Vein ThrombosisCanada
-
University Hospital, BrestCompletedRecurrent Venous Thromboembolism | Idiopathic Deep Vein ThrombosisFrance
-
University of OklahomaPfizerCompleted
-
University of PadovaCompleted
Clinical Trials on curving introducer Günther Tulip Filter
-
Cook Group IncorporatedCompletedVenous Thromboembolism | Pulmonary EmbolismUnited States
-
Cook Research IncorporatedCompleted